E. Anthony Figg
Rothwell Figg Ernst & ManbeckGeneral
Experience25 yrs
Elite Ratings
--
Practice Areas
Chemical Biotech (18 cases)
Biotech (54 cases)
Chemical (12 cases)
Software, Security (1 case)
Communications (2 cases)
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
L3
E
CAFC
L1
D
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:25-CV-00074 | Regeneron Pharma Inc v. Amgen Inc | 07/31/25 | Challenger | |
| 1:24-CV-00780 | Bristol Myers Squibb Co v. Synthon BV | 07/02/24 | Challenger | |
| 1:24-CV-00039 | Regeneron Pharma Inc v. Amgen Inc | 04/16/24 | ||
| 1:24-MD-03103 | In Re: Aflibercept Patent Litigation | 04/11/24 | ||
| 2:24-CV-00264 | Regeneron Pharma Inc v. Amgen Inc | 01/10/24 | Challenger | |
| 1:21-CV-00817 | PF Prism Imb BV v. Synthon Pharma Inc | 10/21/21 | Challenger | |
| 1:21-CV-00157 | Pfizer Inc v. Synthon Pharma Inc | 02/25/21 | Challenger | |
| 1:21-CV-00284 | Pfizer Inc v. Synthon Pharma Inc | 02/24/21 | Challenger | |
| 2:17-CV-01023 | Sherwin Williams Co v. PPG Industries Inc | 08/04/17 | ||
| 1:17-CV-00390 | Teva Pharma USA Inc v. Synthon Pharma Inc | 04/07/17 | Challenger |